scholarly article | Q13442814 |
P819 | ADS bibcode | 2010PLoSO...510991L |
P356 | DOI | 10.1371/JOURNAL.PONE.0010991 |
P932 | PMC publication ID | 2881871 |
P698 | PubMed publication ID | 20539817 |
P5875 | ResearchGate publication ID | 44665259 |
P50 | author | Julio Montaner | Q1712378 |
Robert S Hogg | Q37837778 | ||
P2093 | author name string | Viviane D Lima | |
P2860 | cites work | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies | Q24656950 | ||
HIV prevalence among aboriginal British Columbians. | Q25257802 | ||
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model | Q29305377 | ||
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. | Q51809092 | ||
Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. | Q54290051 | ||
Population effect of scaling up ART in resource-poor settings | Q56528191 | ||
British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008 | Q57180178 | ||
Can antiretroviral therapy eliminate HIV transmission? | Q60343078 | ||
Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco | Q77697543 | ||
Challenges to HIV prevention--seeking effective measures in the absence of a vaccine | Q81058732 | ||
The search for effective HIV vaccines | Q81111870 | ||
G8 funding for HIV universal access: a new opportunity for transparency | Q83769267 | ||
Economic crisis threatens AIDS fight | Q84326123 | ||
The global burden of typhoid fever | Q29619215 | ||
HIV-prevention science at a crossroads: advances in reducing sexual risk. | Q30378142 | ||
Structural factors associated with an increased risk of HIV and sexually transmitted infection transmission among street-involved youth. | Q33398813 | ||
The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention | Q33828458 | ||
Prioritising prevention strategies for patients in antiretroviral treatment programmes in resource-limited settings | Q33926747 | ||
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy | Q34003391 | ||
Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection | Q34070640 | ||
Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand | Q34116644 | ||
Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan | Q34338902 | ||
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic | Q34554572 | ||
Treatment to prevent recurrent genital herpes | Q34735566 | ||
HIV/AIDS in Vancouver, British Columbia: a growing epidemic | Q37144070 | ||
Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. | Q37175647 | ||
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel | Q37234205 | ||
Estimating vertically acquired HIV infections and the impact of the prevention of mother-to-child transmission program in Zimbabwe: insights from decision analysis models | Q38443642 | ||
Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings | Q38852564 | ||
Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco | Q39909667 | ||
Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic | Q43598380 | ||
The AIDS epidemic--a progress report from Mexico City | Q43991685 | ||
Controlling the HIV epidemic, without a vaccine! | Q44681688 | ||
Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting | Q50137561 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Canada | Q16 |
P304 | page(s) | e10991 | |
P577 | publication date | 2010-06-07 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada | |
P478 | volume | 5 |
Q27310382 | A socio-ecological perspective of access to and acceptability of HIV/AIDS treatment and care services: a qualitative case study research |
Q36493044 | Antiretroviral therapy in prevention of HIV and TB: update on current research efforts |
Q37858895 | Antiretroviral therapy: a key component of a comprehensive HIV prevention strategy |
Q28485334 | Application and validation of case-finding algorithms for identifying individuals with human immunodeficiency virus from administrative data in British Columbia, Canada |
Q35966865 | Assessing the effectiveness of antiretroviral regimens in cohort studies involving HIV-positive injection drug users |
Q34126545 | Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study |
Q35119311 | Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort |
Q34001233 | Cohort profile: Seek and treat for the optimal prevention of HIV/AIDS in British Columbia (STOP HIV/AIDS BC) |
Q43925184 | Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study |
Q22241321 | HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts |
Q36722340 | HIV incidence in men who have sex with men in England and Wales 2001-10: a nationwide population study. |
Q36463726 | HIV stigma and the experiences of young men with voluntary and routine HIV testing |
Q34154129 | HIV treatment as prevention: the key to an AIDS-free generation |
Q35069410 | HIV treatment for prevention |
Q50049779 | HIV treatment optimism and crystal methamphetamine use and initiation among HIV-negative men who have sex with men in Vancouver, Canada: A longitudinal analysis |
Q30376338 | Health prevention in the era of biosocieties: a critical analysis of the 'Seek-and-Treat' paradigm in HIV/AIDS prevention. |
Q34776035 | High levels of heterogeneity in the HIV cascade of care across different population subgroups in British Columbia, Canada |
Q38958720 | How long do physicians wait to start antiretroviral treatment in newly diagnosed HIV-infected patients? |
Q37935620 | Mathematical models for the study of HIV spread and control amongst men who have sex with men. |
Q36377371 | Mediators of antiretroviral adherence: a multisite international study |
Q50183631 | Mobile Health Intervention to Reduce HIV Transmission: A Randomized Trial of Behaviorally Enhanced HIV Treatment as Prevention (B-TasP). |
Q36486234 | Modelling the impact of antiretroviral therapy on the epidemic of HIV |
Q36404797 | Non-HIV-related health care utilization, demographic, clinical and laboratory factors associated with time to initial retention in HIV care among HIV-positive individuals linked to HIV care |
Q39793755 | Prescription Opioid Injection Among HIV-Positive People Who Inject Drugs in a Canadian Setting |
Q35051376 | Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention |
Q34640731 | Process monitoring of an HIV treatment as prevention program in British Columbia, Canada |
Q38785377 | Seroadaptive Strategies of Vancouver Gay and Bisexual Men in a Treatment as Prevention Environment. |
Q83869299 | Sexual HIV transmission and antiretroviral therapy: a prospective cohort study of behavioral risk factors among men and women living with HIV/AIDS |
Q35532871 | The Impact of Implementing a Test, Treat and Retain HIV Prevention Strategy in Atlanta among Black Men Who Have Sex with Men with a History of Incarceration: A Mathematical Model |
Q38154428 | The impact of HIV treatment as prevention in the presence of other prevention strategies: lessons learned from a review of mathematical models set in resource-rich countries |
Q35019915 | The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection |
Search more.